# Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

> **NCT03045653** · PHASE2 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 30 (actual)

## Conditions studied

- Breast Cancer Metastatic

## Interventions

- **DRUG:** Tamoxifen Oral Product

## Key facts

- **NCT ID:** NCT03045653
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2019-02-21
- **Final completion:** 2019-02-21
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03045653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03045653, "Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03045653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*